SCHEMBL23811615

SCHEMBL23811615

CN(C)C(=O)c1ccc2c(c1)CC1(CCNCC1)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OTUD7B Q6GQQ9 3/20 0.41
OPRD1 P41143 2/20 0.40
CYP2D6 P10635 2/20 0.40
KCNH2 Q12809 1/20 0.40
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
PDK2 Q15119 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM1A O60341 1/20 0.35
MAOB P27338 1/20 0.35
RCOR1 Q9UKL0 1/20 0.35
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29604529 1.00 OTUD7B (0.41) OTUD7BOPRD1CYP2D6KCNH2GABRD
SCHEMBL30948433 0.82 ALDH1A1 (0.46) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL30948434 0.82 ALDH1A1 (0.46) GABRDGABRA1GABRB1GABRA5GABRA3
SCHEMBL31657080 0.81 KDM1A (0.44) OPRD1CYP2D6KCNH2GABRDGABRA1
SCHEMBL22789664 0.81 KDM1A (0.44) OPRD1CYP2D6KCNH2GABRDGABRA1
SCHEMBL12608360 0.77 HTR2C (0.50) OPRD1ALDH1A1
SCHEMBL29604753 0.77 SMYD3 (0.40) OTUD7BOPRD1CYP2D6GABRDGABRA1
SCHEMBL30341789 0.76 OTUD7B (0.46) OTUD7BOPRD1CYP2D6KCNH2PDK2
SCHEMBL23024527 0.75 OTUD7B (0.38) OTUD7BOPRD1CYP2D6KCNH2PDK2
SCHEMBL30529476 0.75 OTUD7B (0.38) OTUD7BOPRD1CYP2D6KCNH2PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3878853-A1 NITROGEN-CONTAINING FUSED HETEROCYCLIC SHP2 INHIBITOR COMPOUND, PREPARATION METHOD, AND USE Shanghai Ringene BioPharma Co., Ltd. (CN) 2021-09-15 EP disclosed